海王生物连收7个涨停板

Core Viewpoint - The stock of Haiwang Biological has experienced a significant surge, achieving a total increase of 94.90% over a series of consecutive trading days, with a current price of 4.97 yuan per share [2] Trading Performance - The stock has reached a limit-up for seven consecutive trading days, with a trading volume of 28.92 million shares and a turnover of 144 million yuan as of 9:25 AM [2] - The latest total market capitalization of the A-shares is 13.077 billion yuan, with a circulating market capitalization of 13.053 billion yuan [2] Margin Trading Data - As of December 3, the margin trading balance for the stock is 236 million yuan, with a financing balance of 235 million yuan, reflecting a decrease of 14.98 million yuan or 6.00% from the previous trading day [2] - Over the past seven days, the margin trading balance has increased by 59.14 million yuan, representing a growth of 33.65% [2] Institutional Activity - The stock has appeared on the龙虎榜 (Dragon and Tiger List) three times due to significant price deviations, with institutional net purchases totaling 22.32 million yuan and a cumulative net sell of 20.01 million yuan from the Shenzhen Stock Connect [2] - The total net buying from brokerage seats amounts to 86.24 million yuan [2] Company Background - Shenzhen Haiwang Biological Engineering Co., Ltd. was established on December 13, 1992, with a registered capital of 2.631 billion yuan [2]